These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32736231)

  • 1. Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy.
    Qian J; Xu Z; Meng C; Liu J; Hsu PL; Li Y; Zhu W; Yang Y; Morris-Natschke SL; Lee KH; Zhang Y; Ling Y
    Eur J Med Chem; 2020 Oct; 204():112610. PubMed ID: 32736231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Phenylmethylenecyclohexenone Derivatives as Potent TrxR Inhibitors Display High Antiproliferative Activity and Induce ROS, Apoptosis, and DNA Damage.
    Wang X; Qian J; Zhu P; Hua R; Liu J; Hang J; Meng C; Shan W; Miao J; Ling Y
    ChemMedChem; 2021 Feb; 16(4):702-712. PubMed ID: 33085980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of novel methylenecyclohexenone derivatives as TrxR inhibitors in suppressing the proliferation and metastasis of human cancer cells.
    Meng C; Qian J; Xu Z; Liu J; Shan W; Zhu P; Zhu W; Miao J; Ling CC; Ling Y
    Bioorg Chem; 2020 Dec; 105():104360. PubMed ID: 33074118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor.
    Fan QZ; Zhou J; Zhu YB; He LJ; Miao DD; Zhang SP; Liu XP; Zhang C
    Bioorg Chem; 2020 Dec; 105():104401. PubMed ID: 33113415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
    Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM
    J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
    Yan J; Xu Y; Jin X; Zhang Q; Ouyang F; Han L; Zhan M; Li X; Liang B; Huang X
    Eur J Med Chem; 2022 Jan; 227():113897. PubMed ID: 34649064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy.
    Shao FY; Du ZY; Ma DL; Chen WB; Fu WY; Ruan BB; Rui W; Zhang JX; Wang S; Wong NS; Xiao H; Li MM; Liu X; Liu QY; Zhou XD; Yan HZ; Wang YF; Chen CY; Liu Z; Chen HY
    Oncotarget; 2015 Oct; 6(31):30939-56. PubMed ID: 26439985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
    Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors.
    Cheng Y; Qi Y
    Anticancer Agents Med Chem; 2017; 17(8):1046-1069. PubMed ID: 28270080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents.
    Wang Y; Zhang W; Dong J; Gao J
    Bioorg Chem; 2020 Jan; 95():103530. PubMed ID: 31887477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells.
    Liang YW; Zheng J; Li X; Zheng W; Chen T
    Eur J Med Chem; 2014 Sep; 84():335-42. PubMed ID: 25036792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lichen Acids May Be Used as A Potential Drug For Cancer Therapy; by Inhibiting Mitochondrial Thioredoxin Reductase Purified From Rat Lung.
    Ozgencli I; Budak H; Ciftci M; Anar M
    Anticancer Agents Med Chem; 2018; 18(11):1599-1605. PubMed ID: 29793415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase.
    Zhang J; Yao J; Peng S; Li X; Fang J
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):129-138. PubMed ID: 27777067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
    Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
    Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting thioredoxin reductase by eupalinilide B promotes apoptosis of colorectal cancer cells in vitro and in vivo.
    Duan D; Guo X; Tian J; Li M; Jin X; Wang Z; Wang L; Yan Y; Xiao J; Song P; Wang X
    Chem Biol Interact; 2024 Aug; 399():111137. PubMed ID: 38977166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling.
    Zhu P; Qian J; Xu Z; Meng C; Liu J; Shan W; Zhu W; Wang Y; Yang Y; Zhang W; Zhang Y; Ling Y
    J Nat Prod; 2020 Oct; 83(10):3041-3049. PubMed ID: 33026807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of naphthazarin derivatives and identification of novel thioredoxin reductase inhibitor as potential anticancer agent.
    Zhang J; Liu Y; Shi D; Hu G; Zhang B; Li X; Liu R; Han X; Yao X; Fang J
    Eur J Med Chem; 2017 Nov; 140():435-447. PubMed ID: 28987605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells.
    Shao FY; Wang S; Li HY; Chen WB; Wang GC; Ma DL; Wong NS; Xiao H; Liu QY; Zhou GX; Li YL; Li MM; Wang YF; Liu Z
    Oncotarget; 2016 Feb; 7(6):6790-808. PubMed ID: 26758418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
    Ai Y; Zhu B; Ren C; Kang F; Li J; Huang Z; Lai Y; Peng S; Ding K; Tian J; Zhang Y
    J Med Chem; 2016 Mar; 59(5):1747-60. PubMed ID: 26891099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.